These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1066183

  • 21. Bone marrow fibroblasts-conditioned medium regulates the proliferation of leukemic cells.
    Kubota T, Nagao T, Arimori S.
    Tokai J Exp Clin Med; 1988 Feb; 13(1):45-51. PubMed ID: 3232161
    [Abstract] [Full Text] [Related]

  • 22. [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment].
    Gotoh A, Kawanishi Y, Kurosawa K, Miyazawa K, Ohtaka M, Aizawa S, Kimura Y, Yoshikawa O, Toyama K.
    Rinsho Ketsueki; 1993 Jul; 34(7):821-8. PubMed ID: 7689660
    [Abstract] [Full Text] [Related]

  • 23. Effect of the interval between exposures to cytarabine on its cytotoxic action on HL-60 myeloid leukemic cells.
    Leclerc JM, Momparler RL.
    Cancer Treat Rep; 1984 Sep; 68(9):1143-8. PubMed ID: 6592037
    [Abstract] [Full Text] [Related]

  • 24. Effect of interleukin 3 on cytosine arabinoside-mediated cytotoxicity of leukemic myeloblasts.
    Brach M, Klein H, Platzer E, Mertelsmann R, Herrmann F.
    Exp Hematol; 1990 Aug; 18(7):748-53. PubMed ID: 1696204
    [Abstract] [Full Text] [Related]

  • 25. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

  • 26. Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow.
    Chao NJ, Aihara M, Blume KG, Sikic BI.
    Exp Hematol; 1990 Dec; 18(11):1193-8. PubMed ID: 2226679
    [Abstract] [Full Text] [Related]

  • 27. An in vitro model to predict clinical response in adult acute myelogenous leukemia.
    Karp JE, Donehower RC, Burke PJ.
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):172-81. PubMed ID: 3473676
    [Abstract] [Full Text] [Related]

  • 28. Degradation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human leukemic myeloblasts and lymphoblasts.
    Jamieson GP, Finch LR, Snook M, Wiley JS.
    Cancer Res; 1987 Jun 15; 47(12):3130-5. PubMed ID: 3472653
    [Abstract] [Full Text] [Related]

  • 29. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
    Abrahm JL, Gerson SL, Hoxie JA, Tannenbaum SH, Cassileth PA, Cooper RA.
    Cancer Res; 1986 Jul 15; 46(7):3711-6. PubMed ID: 3518922
    [Abstract] [Full Text] [Related]

  • 30. Long-term bone marrow culture induces terminal differentiation of human myeloid leukemic cells.
    Iland HJ, Croaker GM, Repka E, Radloff TJ, Vincent PC.
    Exp Hematol; 1987 Dec 15; 15(11):1109-14. PubMed ID: 3479335
    [Abstract] [Full Text] [Related]

  • 31. Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs.
    Park CH, Wiernik PH, Morrison FS, Amare M, Van Sloten KV, Maloney TR.
    Cancer Res; 1983 May 15; 43(5):2346-9. PubMed ID: 6572563
    [Abstract] [Full Text] [Related]

  • 32. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug 15; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 33. Cell kinetics and chemotherapy in acute leukemia.
    Lampkin BC, McWilliams NB, Mauer AM.
    Semin Hematol; 1972 Apr 15; 9(2):211-23. PubMed ID: 4502317
    [No Abstract] [Full Text] [Related]

  • 34. A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine.
    Momparler RL.
    Cancer Res; 1974 Aug 15; 34(8):1775-87. PubMed ID: 4526298
    [No Abstract] [Full Text] [Related]

  • 35. Differential metabolism of 9-beta-D-arabinofuranosylguanine in human leukemic cells.
    Shewach DS, Mitchell BS.
    Cancer Res; 1989 Dec 01; 49(23):6498-502. PubMed ID: 2819707
    [Abstract] [Full Text] [Related]

  • 36. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells.
    Ho DH, Carter CJ, Brown NS, Hester J, McCredie K, Benjamin RS, Freireich EJ, Bodey GP.
    Cancer Res; 1980 Jul 01; 40(7):2444-6. PubMed ID: 6248205
    [No Abstract] [Full Text] [Related]

  • 37. Potentiation of cytotoxicity of 1-beta-D-arabinofuranosylcytosine for K562 human leukemic cells by cadeguomycin.
    Suzuki H, Kim SH, Tanara M, Okazaki K, Okabe T, Wu RT, Tanaka N.
    Cancer Res; 1987 Feb 01; 47(3):713-7. PubMed ID: 3467840
    [Abstract] [Full Text] [Related]

  • 38. Ultrastructure and cytokinetics of leukemic myeloblasts containing giant granules.
    Parmley RT, Dahl GV, Austin RL, Gauthier PA, Denys FR.
    Cancer Res; 1979 Oct 01; 39(10):3834-44. PubMed ID: 289435
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Correlation of cytosine arabinoside-induced increment in growth fraction of leukemic blast cells with clinical response.
    Vogler WR, Cooper LE, Groth DP.
    Cancer; 1974 Mar 01; 33(3):603-10. PubMed ID: 4544535
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.